NCT Number: NCT04483570
Urological Deterioration in Secondary Tethered Cord Syndrome and Clue to Detect It
Secondary tethered cord syndrome (STCS) has been diagnosed with signs of progressive deterioration in urological or neuroorthopedic systems following primary tethering surgery. However, there is no convincing urological diagnostic clue for STCS.
Looking for future studies?
Notify MeKey information
Conditions
Age range
3 month–23 year
Sex eligibility
All sexes
Study type
Observational
About this study
Tethered cord syndrome (TCS) refers to various problems involving neurologic, orthopedic, and urologic systems, seen as a result of chronic traction of the spinal cord in patients with spinal dysraphism. Evidence for neural injury is often assumed irreversible, so untethering is justified to maintain neural function and prevent further neural damage. Unfortunately, some patients experienced an aggravation of symptoms following untethering. The probable causes are assumed to be the neural injury before or during operation, which was revealed along with dysplastic neural function, neural compression by increasing syrinx and secondary tethered cord syndrome (STCS) in which postoperative neural adhesion or syrinx limit motion of spinal and elicit ischemic changes as the spine grows during puberty. The Secondary Tethered Cord Syndrome is reported as 19% of cases and causes significant progressive morbidities in those who affected.
Unfortunately, the detection of STCS is not as simple as it thought. Although magnetic resonance imaging (MRI) often reveals that the cord seems to get straightened, this does not necessarily mean that is a significant tethering or cord associated with progressive nerve damage. The variable course of progression and involvement of multiple systems such as lower extremity, bladder, bowel, and back would not allow a single specialist to draw conclusions about the presence of secondary tethered cord syndrome. Moreover, the untethering procedure of STCS may not always be safe and effective. Given the fact that a significant number of 'no improvement' or new onset complications following redo-untethering, the surgery could not be attempted without clear evidence. This explains the reason there is only a limited number of relevant studies so far.
In this study, it aims to delinate the genuine features of secondary tethered cord syndrome by selecting and analyzing only cases with symptom improvements. Furthermore, it described their natural history and time course of urological deterioration and characterized by the urodynamic changes before and after the redo-untethering.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Children with signs of progressive deterioration in urological or neuroorthopedic system following primary untethering surgery.
Exclusion criteria
- Children without signs of progressive in urological or neuroorthopedic system following primary untethering surgery.
Treatment and study plan
Primary outcomes
-
Pre-operative evaluation: Dysfunctional voiding
Time frame: Baseline
Evaluating any presence of urinary and fecal incontinence before the secondary tethered cord syndrome operation.
-
Pre-operative evaluation: Presence of Urinary Tract Infection (UTI)
Time frame: Baseline
Evaluating any presence of urinary and fecal incontinence before the secondary tethered cord syndrome operation
-
VUD (Video Urodynamic Studies)
Time frame: Baseline
Measuring maximal cystometric capacity, compliance, estimated bladder capacity before the operation of the secondary tethered cord syndrome.
-
VUD (Video Urodynamic Studies)
Time frame: 1 year after the operation
Measuring changes in maximal cystometric capacity, compliance, estimated bladder after the operation of the secondary tethered cord syndrome
-
VUD (Video Urodynamic Studies)
Time frame: 2 years after the operation
Measuring changes in maximal cystometric capacity, compliance, estimated bladder after the operation of the secondary tethered cord syndrome
Sponsors and collaborators
Lead sponsor
Seoul National University Hospital
Other
Registry information
Important dates
- Study start
- 2011
- Primary completion
- 2018
- Study completion
- 2018
- First posted
- Jul 23, 2020
- Registry last updated
- Jul 23, 2020
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Efficacy and Safety of a Continent Cutaneous Urinary Diversion in Spinal Cord Injury Patients
NCT04936217
Central Nervous System Diseases, Female Urogenital Diseases
Nîmes, Gard, France
View Trial DetailsSafety and Efficacy of a Weekly Oral Cyclic Antibiotic Programme in the Prevention of Urinary Tract Infection on Neurological Bladder
NCT01388413
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Garches, France
View Trial DetailsCentral Nervous System Changes Following OnabotulinumtoxinA Injection in the Bladder
NCT03033355
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Houston, Texas, United States
View Trial DetailsEvaluation of the Efficacy of Transcutaneous Tibial Nerve Stimulation on Post-Stroke Overactive Bladder
NCT06247033
Brain Diseases, Cardiovascular Diseases
Ankara, Cankaya, Turkey (Türkiye)
View Trial Details